These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 25759946)
1. Synthesis of a stabilized 177Lu-siRNA complex and evaluation of its stability and RNAi activity. Fathi M; Yavari K; Taghikhani M; Ghannadi Maragheh M Nucl Med Commun; 2015 Jun; 36(6):636-45. PubMed ID: 25759946 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of dose dependent cytotoxic activity in SW480 colon cancer cells by ¹⁷⁷Lu-labeled siRNA targeting IGF-1R. Fathi M; Taghikhani M; Ghannadi-Maragheh M; Yavari K Nucl Med Biol; 2013 May; 40(4):529-36. PubMed ID: 23618769 [TBL] [Abstract][Full Text] [Related]
3. SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation. Yavari K; Taghikhani M; Maragheh MG; Mesbah-Namin SA; Babaei MH; Arfaee AJ; Madani H; Mirzaei HR Acta Oncol; 2010; 49(1):70-5. PubMed ID: 20001499 [TBL] [Abstract][Full Text] [Related]
4. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro]. Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222 [TBL] [Abstract][Full Text] [Related]
5. Effects of Type 1 Insulin-Like Growth Factor Receptor Silencing in a Human Adrenocortical Cell Line. Ribeiro TC; Jorge AA; Montenegro LR; Almeida MQ; Ferraz-de-Souza B; Nishi MY; Mendonca BB; Latronico AC Horm Metab Res; 2016 Jul; 48(7):484-8. PubMed ID: 27246621 [TBL] [Abstract][Full Text] [Related]
6. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
7. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells. Rao W; Li H; Song F; Zhang R; Yin Q; Wang Y; Xi Y; Ge H Carcinogenesis; 2014 Jul; 35(7):1573-81. PubMed ID: 24667688 [TBL] [Abstract][Full Text] [Related]
8. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro. Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144 [TBL] [Abstract][Full Text] [Related]
10. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells. Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor. Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904 [TBL] [Abstract][Full Text] [Related]
12. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells. Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma. Shu S; Li X; Yang Y; Zhang Y; Li T; Liang C; Wan J Int Immunopharmacol; 2011 Feb; 11(2):244-9. PubMed ID: 21145998 [TBL] [Abstract][Full Text] [Related]
16. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53. Niu J; Xu Z; Li XN; Han Z Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318 [TBL] [Abstract][Full Text] [Related]
17. Silencing insulin-like growth factor-1 receptor expression inhibits gastric cancer cell proliferation and invasion. Ge J; Chen Z; Huang J; Yuan W; Den Z; Chen Z Mol Med Rep; 2015 Jan; 11(1):633-8. PubMed ID: 25339573 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line. Shali H; Shabani M; Pourgholi F; Hajivalili M; Aghebati-Maleki L; Jadidi-Niaragh F; Baradaran B; Movassaghpour Akbari AA; Younesi V; Yousefi M Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):293-302. PubMed ID: 28362176 [TBL] [Abstract][Full Text] [Related]
19. Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor. Åberg M; Eriksson O; Mokhtari D; Siegbahn A Thromb Haemost; 2014 Apr; 111(4):748-60. PubMed ID: 24336871 [TBL] [Abstract][Full Text] [Related]
20. Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivo. Zhao H; Gu X World J Surg Oncol; 2014 Nov; 12():325. PubMed ID: 25363593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]